Related Experiment Videos

Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice

H Murakami1, Y Takahagi, M Yoshitatsu

  • 1Research and Development Center, Nippon Meat Packers, Inc., Tsukuba, Ibaraki, Japan.

Immunobiology
|June 2, 2000
PubMed

Insights

The porcine membrane cofactor protein (pMCP) gene promoter efficiently drives expression of human decay-accelerating factor (DAF) in transgenic mice. This finding supports pMCP promoter use for xenotransplantation.

Area of Science:

  • Immunology
  • Genetics
  • Transplantation Biology

Background:

  • Porcine membrane cofactor protein (pMCP) is a complement regulatory protein highly expressed on vascular endothelium.
  • Efficient expression of complement regulatory proteins is crucial for xenotransplantation success.

Purpose of the Study:

  • To investigate the potential of the pMCP gene promoter to drive expression of human decay-accelerating factor (DAF; CD55) in transgenic mice.
  • To assess the functional consequences of DAF expression in transgenic mice for xenotransplantation.

Main Methods:

  • Generation of transgenic mice using pMCP promoter fragments (0.9 kb and 5.4 kb) linked to a human DAF minigene.
  • Immunohistochemical analysis of hDAF expression in various organs of transgenic mice.
  • Flow cytometry to quantify hDAF surface expression on red blood cells and splenocytes.
  • Assessment of resistance to human serum lysis and ex vivo heart function in a Langendorff perfusion system.

Main Results:

  • The pMCP promoter fragments successfully directed hDAF expression in vascular endothelium and nerves across multiple organs.
  • Transgenic mice exhibited elevated hDAF surface expression on blood cells compared to human cells.
  • Cells and organs from transgenic mice showed resistance to human serum-mediated lysis and improved function.

Conclusions:

  • The pMCP gene promoter is an effective regulatory element for driving transgene expression in mice.
  • This promoter is a promising candidate for developing transgenic animals for xenotransplantation, enhancing complement-mediated protection.

Related Concept Videos